OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
300857 Sharetronic Data Technology
- 112.83
- -3.82-3.27%
Market Closed Apr 1 15:00 CST
27.67BMarket Cap40.00P/E (TTM)
115.56High110.92Low93.60KlotVolume115.00Open116.65Pre Close1.05BTurnover3.83%Turnover Ratio40.00P/E (Static)245.26MShares141.8852wk High8.61P/B27.59BFloat Cap44.2252wk Low139.98Limit Up244.56MShs Float141.88Historical High93.32Limit Down3.98%Amplitude11.99Historical Low0.11Dividend TTM112.60Avg Price52.28KlotAsk0.10%Div YieldTTM100Lot Size34.65KlotBid
Sharetronic Data Technology Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 59.08%7.41B | 67.11%5.39B | 94.51%3.58B | 118.38%1.76B | 47.95%4.66B | 46.37%3.23B | 35.76%1.84B | 17.55%805.41M | 6.37%3.15B | -5.23%2.21B |
| Operating revenue | 59.08%7.41B | 67.11%5.39B | 94.51%3.58B | 118.38%1.76B | 47.95%4.66B | 46.37%3.23B | 35.76%1.84B | 17.55%805.41M | 6.37%3.15B | -5.23%2.21B |
| Other operating revenue | 58.81%81.26M | ---- | -70.95%6.31M | ---- | -2.52%51.17M | ---- | -0.21%21.71M | ---- | 147.47%52.49M | ---- |
| Interest income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Commission income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Premiums earned | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Total operating cost | 52.02%6.54B | 58.77%4.72B | 83.94%3.12B | 106.68%1.55B | 43.95%4.3B | 43.65%2.97B | 33.55%1.69B | 14.66%749.44M | 5.26%2.99B | -6.82%2.07B |
| Operating cost | 52.07%6.12B | 58.55%4.43B | 85.87%2.95B | 110.26%1.47B | 44.04%4.03B | 44.19%2.8B | 34.18%1.59B | 15.81%699.89M | 6.80%2.8B | -6.16%1.94B |
| Operating tax surcharges | 67.65%17.18M | 78.27%13.14M | 76.03%9.12M | 134.93%4.83M | 44.71%10.25M | 54.17%7.37M | 83.95%5.18M | 81.23%2.06M | -27.53%7.08M | -30.83%4.78M |
| Operating expense | 79.61%32.12M | 72.73%21.75M | 73.30%12.91M | 61.17%5.58M | 50.16%17.88M | 43.08%12.59M | 24.06%7.45M | 8.01%3.46M | -30.31%11.91M | -32.31%8.8M |
| Administration expense | 49.86%133.79M | 65.46%96.14M | 83.76%62.4M | 86.05%27.75M | 30.28%89.28M | 9.40%58.11M | -6.64%33.96M | -22.12%14.92M | 7.17%68.53M | 8.68%53.12M |
| Financial expense | -2,244.11%-8.92M | 247.12%7.5M | -18,205.22%-12.81M | -158.39%-3.96M | -78.01%416.17K | 46.72%-5.1M | 98.13%-69.98K | 13.44%6.77M | -93.19%1.89M | -159.02%-9.57M |
| -Interest expense (Financial expense) | 107.43%49.34M | 102.59%35.42M | 93.47%23.11M | 70.73%10.08M | -2.12%23.79M | -2.73%17.49M | 4.78%11.94M | 24.33%5.9M | 54.66%24.3M | 48.62%17.98M |
| -Interest Income (Financial expense) | -56.31%-27.12M | -84.64%-20.34M | -202.56%-15.15M | -537.55%-7.88M | -469.10%-17.35M | -446.95%-11.02M | -334.25%-5.01M | -287.46%-1.24M | -71.53%-3.05M | -51.82%-2.01M |
| Research and development | 53.84%240.63M | 42.56%146.14M | 55.49%90.81M | 92.99%43.11M | 52.28%156.41M | 41.79%102.52M | 36.68%58.4M | 12.83%22.34M | 0.55%102.71M | 5.24%72.3M |
| Credit Impairment Loss | -229.56%-55.81M | -34.86%-36.9M | -211.02%-36.99M | -394.55%-16.96M | -102.21%-16.94M | -183.54%-27.36M | -90.99%-11.89M | 19.07%-3.43M | 32.10%-8.38M | 14.04%-9.65M |
| Asset Impairment Loss | -74.92%-53.14M | -51.57%-22.71M | -47.09%-16.84M | -33.68%-7.74M | 1.86%-30.38M | -0.13%-14.99M | -49.29%-11.45M | -74.74%-5.79M | -221.69%-30.96M | -64.33%-14.97M |
| Other net revenue | -105.19%-84.32M | -20.36%-54.34M | -126.62%-53.15M | -381.54%-27.23M | -104.61%-41.1M | -286.79%-45.15M | -165.14%-23.45M | -668.42%-5.66M | -406.66%-20.09M | -2,413.10%-11.67M |
| Fair value change income | -150.82%-570.93K | 184.07%1.85M | -982.68%-1.42M | -251.58%-2.36M | 649.98%1.12M | -124.91%-2.2M | 94.71%-130.71K | 530.16%1.55M | 68.81%-204.29K | 714.41%8.85M |
| Invest income | 17.04%-10.19M | 18.06%-7.89M | 7.69%-5.35M | -358.10%-3.57M | -104.18%-12.28M | 48.42%-9.63M | -31.70%-5.8M | -161.36%-779.13K | -207.66%-6.01M | -927.88%-18.67M |
| Net open hedge income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| -Including: Investment income associates | -19.80%-8.5M | -11.07%-8.1M | 5.77%-4.42M | 14.69%-2.44M | -181.89%-7.1M | -97.96%-7.29M | -75.49%-4.69M | -124.01%-2.86M | ---2.52M | ---3.68M |
| Exchange income | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Asset deal income | 95.08%-73.82K | 83.54%-84.68K | 123.00%51.76K | ---339.38K | -334.91%-1.5M | -189.83%-514.54K | -134.33%-225K | --0 | 3,709.23%638.79K | 14,061.57%572.78K |
| Other revenue | 87.85%35.46M | 19.39%11.4M | 22.40%7.39M | 33.84%3.74M | -23.97%18.88M | -56.99%9.55M | -46.40%6.04M | -60.29%2.79M | 5.38%24.83M | 26.88%22.19M |
| Operating profit | 149.35%787.19M | 193.58%623.87M | 234.92%409.03M | 263.11%182.71M | 124.85%315.7M | 68.75%212.5M | 57.19%122.13M | 54.59%50.32M | 9.73%140.41M | 16.07%125.93M |
| Add:Non operating Income | -81.23%285.84K | -98.48%22.72K | -98.48%18.27K | -99.99%19.05 | 55.10%1.52M | 48.16%1.5M | 22.65%1.2M | -67.37%200.77K | -67.76%981.78K | 138.32%1.01M |
| Less:Non operating expense | 308.38%2.13M | 428.88%1M | 309.56%572.23K | -90.43%72.13K | -59.95%522K | -60.54%189.7K | -67.37%139.72K | 80.27%753.83K | -17.49%1.3M | -28.69%480.71K |
| Total profit | 147.98%785.34M | 191.33%622.89M | 231.58%408.47M | 267.00%182.64M | 126.08%316.7M | 69.08%213.81M | 57.44%123.19M | 51.97%49.76M | 8.24%140.08M | 16.82%126.46M |
| Less:Income tax cost | 221.52%98.25M | 242.13%69.58M | 360.31%51.29M | 366.04%20.09M | 232.29%30.56M | 91.60%20.34M | 49.91%11.14M | 42.30%4.31M | 64.28%9.2M | 46.04%10.61M |
| Net profit | 140.12%687.09M | 185.99%553.31M | 218.78%357.18M | 257.61%162.55M | 118.61%286.14M | 67.01%193.47M | 58.23%112.05M | 52.96%45.45M | 5.71%130.89M | 14.72%115.84M |
| Net profit from continuing operation | 140.12%687.09M | 185.99%553.31M | 218.78%357.18M | 257.61%162.55M | 118.61%286.14M | 67.01%193.47M | 58.23%112.05M | 52.96%45.45M | 5.71%130.89M | 14.72%115.84M |
| Net income from discontinuing operating | ---- | ---- | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- |
| Less:Minority Profit | -308.61%-4.7M | -58.58%-3.72M | 38.33%-596.95K | 167.04%303.86K | -5,571.44%-1.15M | -5,654.49%-2.35M | -292.19%-968.04K | -388.31%-453.22K | 99.17%-20.27K | 101.54%42.23K |
| Net profit of parent company owners | 140.80%691.78M | 184.46%557.03M | 216.58%357.78M | 253.42%162.25M | 119.46%287.29M | 69.10%195.82M | 59.04%113.01M | 55.31%45.91M | 3.67%130.91M | 11.65%115.8M |
| Earning per share | ||||||||||
| Basic earning per share | 130.08%2.83 | 169.25%2.2787 | 194.00%1.47 | 204.55%0.67 | 95.24%1.23 | 50.96%0.8463 | 47.06%0.5 | 57.14%0.22 | 3.28%0.63 | 12.12%0.5606 |
| Diluted earning per share | 130.08%2.83 | 169.25%2.2787 | 194.00%1.47 | 204.55%0.67 | 95.24%1.23 | 50.96%0.8463 | 47.06%0.5 | 57.14%0.22 | 3.28%0.63 | 12.12%0.5606 |
| Other composite income | 452.25%6.22M | -18.63%1.49M | -102.18%-50.75K | 58.12%-828.47K | -86.10%1.13M | -79.65%1.83M | -42.05%2.32M | -251.24%-1.98M | 523.22%8.1M | 2,568.31%8.98M |
| Other composite income of parent company owners | 286.87%4.36M | -13.45%1.58M | -102.50%-58.17K | 57.98%-831.26K | -86.10%1.13M | -79.65%1.83M | -42.05%2.32M | -251.24%-1.98M | 523.22%8.1M | 2,568.31%8.98M |
| Other composite income of minority owners | 13,062,203.72%1.86M | -10,068,485.11%-94.64K | 27,873.36%7.42K | 39,649.72%2.79K | -36.33%-14.26 | -121.86%-0.94 | -988.04%-26.73 | -346.84%-7.06 | -28.66%-10.46 | --4.3 |
| Total composite income | 141.35%693.31M | 184.07%554.8M | 212.26%357.13M | 271.98%161.72M | 106.68%287.26M | 56.46%195.3M | 52.85%114.37M | 49.13%43.48M | 14.01%138.99M | 24.06%124.82M |
| Total composite income of parent company owners | 141.37%696.14M | 182.63%558.61M | 210.15%357.72M | 267.44%161.41M | 107.48%288.41M | 58.40%197.65M | 53.64%115.34M | 51.50%43.93M | 11.78%139.01M | 20.73%124.78M |
| Total composite income of minority owners | -146.57%-2.83M | -62.62%-3.81M | 39.10%-589.53K | 167.66%306.65K | -5,568.58%-1.15M | -5,653.93%-2.35M | -292.21%-968.07K | -388.32%-453.22K | 99.17%-20.28K | 101.54%42.23K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.